Additionally, Gallipoli et al. [28] found that JAK2 inhibitors affected JAK-STAT pathway activity in vitro by inducing apoptosis of CML progenitor cells. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.